CSP #2005 - Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy Trial (VALOR)
This study is comparing two common treatments for early-stage non-small cell lung cancer: surgery and stereotactic radiotherapy, which is a type of high-precision radiation therapy. Doctors want to find out if one of these treatments might work better than the other.
This study is currently recruiting patients with early-stage non-small cell lung cancer whose main tumor is 5 centimeters or smaller and who are able to carry out normal daily activities. People whose cancer has spread or who have had certain past chest surgeries or radiation cannot join. The study takes place at VA medical centers for veterans who receive VA care; a thoracic surgeon must judge you fit for surgery and a radiation oncologist must judge you suitable for stereotactic radiotherapy (SBRT).
Each participant's group is chosen at random, by chance, rather than by you or your doctor. One group will receive stereotactic radiotherapy, while the comparison group will undergo surgery to remove a specific section of the lung.
The study is currently active and recruiting participants at 12 Veterans Affairs (VA) medical centers in the United States.
- 1The study compares surgery with stereotactic radiotherapy for early-stage lung cancer.
- 2Treatment groups are assigned completely by chance.
- 3The study is currently taking new participants at 12 Veterans Affairs (VA) medical centers in the United States.
Related video
Related links
Outside pages about this study, checked by our team
This summary was generated using AI and may not capture all details. Always consult with a healthcare professional for medical advice.